NURR1 agonists (Karo Pharma)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameNURR1 agonists (Karo Pharma)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNuclear receptor subfamily 4 group A member 2 agonists
TargetsNuclear receptor subfamily 4 group A member 2
Therapy Area/IndicationsAutoimmune DiseasesParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKaro Pharma Ab
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKaro Pharma Ab
Active IndicationsN/A
Inactive IndicationsAutoimmune DiseasesParkinson Disease

Other Information

ATC CodeN/A
Related LinksN/A